Hyperactivity of mTORC1- and mTORC2-dependent signaling mediates epilepsy downstream of somatic PTEN loss

• Published in: eLife 2024-03, Vol.12
• Main Authors: Cullen, Erin R, Safari, Mona, Mittelstadt, Isabelle, Weston, Matthew C
• Format: Article
• Language: English
• Subjects: 1-Phosphatidylinositol 3-kinase; AKT protein; Analysis; Animals; Brain; Cerebral Cortex; Convulsions & seizures; EEG; Epilepsy; Epilepsy - genetics; focal; Genetic aspects; Humans; Hyperactivity; Hypotheses; Kinases; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Mortality; mTOR; Neurons; Proteins; PTEN Phosphohydrolase - genetics; PTEN protein; Seizures; Seizures (Medicine); somatic; TOR protein
• ISSN: 2050-084X; 2050-084X
• DOI: 10.7554/eLife.91323

Gene variants that hyperactivate PI3K-mTOR signaling in the brain lead to epilepsy and cortical malformations in humans. Some gene variants associated with these pathologies only hyperactivate mTORC1, but others, such as , , and , hyperactivate both mTORC1- and mTORC2-dependent signaling. Previous work established a key role for mTORC1 hyperactivity in mTORopathies, however, whether mTORC2 hyperactivity contributes is not clear. To test this, we inactivated mTORC1 and/or mTORC2 downstream of early deletion in a new mouse model of somatic loss-of-function (LOF) in the cortex and hippocampus. Spontaneous seizures and epileptiform activity persisted despite mTORC1 or mTORC2 inactivation alone, but inactivating both mTORC1 and mTORC2 simultaneously normalized brain activity. These results suggest that hyperactivity of both mTORC1 and mTORC2 can cause epilepsy, and that targeted therapies should aim to reduce activity of both complexes.